Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients – Stanford Medical Center Report

Email Tweet Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19. Jun 30 2020 Aruna Subramanian is investigating an antiviral drug, favipiravir, to see if it reduces symptoms and viral shedding… Read More »

How often do you need malaria vaccine

When I first decided to quit my job and sell everything I own to travel, one of the things I most worried about was vaccines. I knew that I wanted to spend my time primarily exploring developing countries and I was concerned about exposing myself to dangerous tropical diseases. Despite all of this, I struggled… Read More »